Title Anticipated publication date
Abdominal aortic aneurysm 20171001
Accident and emergency departments 20150501
Acute heart failure - diagnosis and management in adults 20151201
Acute medical emergencies in adults and young people , service guidance 20161101
Air pollution - outdoor air quality and health 00010101
Anaemia management in chronic kidney disease (update) 20150601
Ankylosing spondylitis and axial spondyloarthritis (non-radiographic) - adalimumab, etanercept infliximab and golimumab (inc rev TA143 and TA233) ID694 00010101
Antenatal and postnatal mental health 20151001
Antimicrobial stewardship 20150701
Antimicrobial stewardship - changing risk-related behaviours in the general population 20160301
Arthritis (juvenile idiopathic) - abatacept, adalimumab, etanercept and tocilizumab (inc review TA35) [ID738] 20160201
Assessment and Management of Cirrhosis 20160601
Asthma - diagnosis and monitoring 20150701
Asthma management 20170601
Atherothrombotic events - vorapaxar [ID616] 00010101
Atrial fibrillation 20150701
Atrial fibrillation - clopidogrel (in combination with aspirin) [ID95] 00010101
Atrial fibrillation - idraparinux sodium [ID375] 00010101
Atrial fibrillation - vernakalant [ID454] 00010101
Atrial fibrillation - ximelagatran [ID376] 00010101
Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624] 00010101
Attention deficit hyperactivity disorder (standing committee B update) 20160201
Autologous unmanipulated peripheral blood stem cell therapy for multiple sclerosis 00010101
Bipolar disorder in adults 20150601
Bipolar disorder, psychosis and schizophrenia in children and young people 20151001
Bladder cancer 20151201
Bone loss (therapy-induced) in non-metastatic breast cancer - denosumab [ID83] 00010101
Bone metastases (hormone refractory prostate cancer) - denosumab [ID405] 00010101
Breast cancer - intensity modulated radiotherapy [ID16] 00010101
Breast cancer (advanced and/or metastatic) - sunitinib (in combination with capecitabine) [ID319] 00010101
Breast cancer (advanced or metastatic) - lapatinib [ID20] 00010101
Breast cancer (advanced or metastatic) hormone-sensitive - lapatinib [ID115] 00010101
Breast cancer (early) - intrabeam radiotherapy system [ID618] 00010101
Breast cancer (ErbB2 HER2, metastatic) - lapatinib (with paclitaxel, 1st line) [ID517] 00010101
Breast cancer (first line treatment) - sunitinib (in combination with a taxane) [ID58] 00010101
Breast cancer (HER2 negative, metastatic) - bevacizumab (2nd line) [ID488] 00010101
Breast cancer (HER2 positive, metastatic) - pertuzumab (with trastuzumab and docetaxel) [ID523] 00010101
Breast cancer (HER2 positive, unresectable) - trastuzumab emtansine (after trastuzumab and taxane) [ID603] 00010101
Breast cancer (locally advanced or metastatic) - ixabepilone [ID377] 00010101
Breast cancer (metastatic) -trastuzumab (as monotherapy and in combination with a taxane) [ID345] 20111001
Bronchiolitis in children 20150601
Cardiac transplantation (rejection) - everolimus [ID114] 00010101
Cardiovascular risk assessment 20150901
Care and support of older people with learning disabilities 20171001
Care of the dying adult 20151201
Cataracts 20170601
Cerebral Palsy 20161001
Cervical ripening ballon for the induction of labour in women who have previously undergone cesarean section 00010101
Challenging behaviour and learning disabilities 20151001
Challenging behaviour and learning disabilities 20150501
Chest pain of recent onset (standing committee A update) 20160101
Child abuse and neglect 20170901
Children's attachment 20151001
Chronic heart failure (QS update) 20160201
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox [ID350] 00010101
Chronic obstructive pulmonary disease (QS update) 20160101
Clinically isolated syndrome - beta interferons and glatiramer acetate [ID109] 00010101
Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease 00010101
Clostridium difficile associated diarrhoea - tolevamer [ID378] 00010101
Coeliac disease 20150901
Colon cancer (adjuvant) - irinotecan [ID379] 00010101
Colorectal cancer (metastatic) - cetuximab (review TA176) and panitumumab (part review TA240) (1st line) ID794 20160401
Community engagement (update) 20160201
Community nursing care settings 20160301
Complex fractures 20160201
Constipation (opioid induced) - lubiprostone [ID646] 20141001
Constipation (opioid-induced) - naloxegol [ID674] 20150701
Coronary heart disease - cangrelor [ID698] 20150801
Crohn's disease - Tests for therapeutic monitoring of TNF inhibitors (LISA-TRACKER ELISA kits, TNFa-Blocker ELISA kits, and Promonitor ELISA kits) 20151201
Crohn's disease (moderate to severe) - vedolizumab [ID690] 00010101
Cutting blocks for total knee arthroplasty 00010101
Cyanoacrylate glue occlusion for varicose veins 00010101
Cystic fibrosis 20170201
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - apixaban [ID726] 20150601
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662] 20151001
Degradable surgical implant 00010101
Dementia (non-Alzheimer) - new pharmaceutical treatments [ID380] 00010101
Dementia (update) 00010101
Depression in adults (update) 20170501
Developmental follow-up of pre-term babies 20170801
Diabetes - buccal insulin [ID311] 00010101
Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy) [ID756] 20160501
Diabetes in children and young people 20150801
Diabetes in pregnancy 20160101
Diabetic foot problems 20150801
Diabetic foot ulcers - new treatments [ID381] 00010101
Diabetic retinopathy - ruboxistaurin [ID382] 00010101
Diagnosing prostate cancer - PROGENSA PCA3 assay and Prostate Health Index 20150501
Diagnosis and monitoring of sepsis: procalcitonin testing (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) 20151001
Diagnostic services 20171101
Disability, dementia and frailty in later life - mid-life approaches to prevention 00010101
Domestic violence 20160201
Drug allergy - diagnosis and management 20150701
Drug Eluting Stents for Sinus Disease 00010101
Drug misuse prevention 20170101
Dry eye disease - ciclosporin [ID665] 20150801
Duchenne muscular dystrophy (nonsense mutation) - ataluren [ID428] 20160201
Dupuytren's contracture - collagenase clostridium histolyticum [ID621] 00010101
Dyspepsia 20150701
Eating disorders (update) 20170401
Electrical stimulation of the lower oesophageal sphincter (LES) for the treatment of gastro-oesophageal reflux disease (GORD) 00010101
Electrochemotherapy for the treatment of malignant melanoma 20130321
Electrotherapy for the treatment of haemorrhoids 00010101
End of life care for infants, children and young people 00010101
Endometriosis 20170501
Endovascular aneurysm sealing (EVAS) for abdominal aortic aneurysm 00010101
Evidence summaries: medicines and prescribing briefings 00010101
Evidence summaries: new medicines 00010101
Evidence summaries: unlicensed/off-label medicines 00010101
Ex utero intrapartum therapy for fetal obstruction 00010101
Extra corporeal membrane oxygenation for acute heart failure in children 00010101
Failure to thrive 20171001
Falls - faller's clinics [ID103] 00010101
Flexible endoscopic treatment of pharyngeal pouch 00010101
Food allergy and anaphylaxis 20160301
Fractures 20160201
Gallstone disease 20151201
Gastric cancer (metastatic) - ramucirumab (after chemotherapy) [ID741] 20160101
Gastrointestinal stromal tumours (unresectable, metastatic) - masitinib (after progression with imatinib) ID622 00010101
Gastro-oesophageal reflux disease in children and young people 20160101
Gaucher disease (type 1) - eliglustat [ID709] 20150801
Generalised anxiety disorder - quetiapine [ID347] 00010101
Glaucoma - lerdelimumab (CAT-152) [ID383] 00010101
Glioblastoma - bevacizumab [ID80] 00010101
Haematological cancers - improving outcomes (update) 20160501
Harmful sexual behaviour among children and young people 20160901
Head and neck cancer - contusugene ladenovec [ID76] 00010101
Head and neck cancer - intensity modulated radiotherapy [ID15] 00010101
Headaches (Standing Committee B update) 20151101
Healthcare associated infections - prevention and management 20160201
Heart failure (acute decompensated) - nesiritide [ID384] 00010101
Heart failure (acute) - serelaxin [ID673] 00010101
HeartFlow FFRct for the computation of fractional flow reserve from coronary CT angiography 20151201
Hepatitis B (adults) - entecavir and tenofovir disoproxil fumarate [ID111] 00010101
Hepatitis C 00010101
Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742] 20150601
Hepatitis C (chronic) - ombitasvir/paritaprevir/ritonavir (with or without dasabuvir) [ID731] 20150901
Hepatitis C (chronic)-daclatasvir [ID766] 20150801
Hepatitis C (genotype 1, chronic) - faldaprevir [ID670] 00010101
Hernia 00010101
HIV testing - increasing uptake among people who may have undiagnosed HIV 20160901
Home care 20150901
Homes - preventing accident and unintentional injury among children and young people under 15 20160101
Hypercholesterolaemia - ezetimibe (review TA132) [ID627] 20160201
Hypercholesterolaemia (primary) and dyslipidaemia (mixed) - alirocumab [ID779] 20160601
Hypercholesterolaemia (primary), dyslipidaemia (mixed) - evolocumab [ID765] 20160401
Hypercholesterolemia - mipomersen [ID524] 00010101
Hyperuricaemia (chronic) in gout - lesinurad [ID761] 20161101
Hypophosphatasia (paediatric-onset) - asfotase alfa [ID758] 20151201
Hysteroscopic morcellation of uterine leiomyomas (fibroids) 00010101
Idiopathic pulmonary fibrosis - nintedanib [ID752] 20160101
Idiopathic pulmonary fibrosis - pirfenidone (review TA282) [ID837]: 20160501
ImmunoCAP ISAC and Microtest for multiplex allergen testing 20160401
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache 00010101
Implanting a baroreceptor stimulation device for resistant hypertension 00010101
In development: local government briefings 00010101
Inpatient mental health settings 20151001
Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section 00010101
Insertion of a Leadless Pacemaker device for Cardiac Arrhythmia 00010101
Insertion of a sub-retinal implant for retinitis pigmentosa 00010101
Insertion of an epiretinal prosthesis for retinitis pigmentosa 00010101
Intrapartum care 20151201
Intrapartum care for high risk women 20170101
Intravaginal sling for stress urinary incontinence 20050321
Intravenous fluids therapy in children 20151101
Irritable bowel syndrome 20160201
Joint distraction for ankle osteoarthritis 00010101
Joint distraction for knee osteoarthritis without alignment correction 00010101
Juvenile idiopathic arthritis - abatacept [ID27] 00010101
Juvenile idiopathic arthritis - adalimumab [ID385] 00010101
Kidney disease (autosomal dominant polycystic) - tolvaptan [ID652] 20150801
Kidney transplantation (adults) - immunosuppressive therapy (Review of TA 85) [ID456] 20151101
Kidney transplantation (children, adolescents) - immunosuppressive regimens (review of TA99) [ID346] 20160101
Kidney transplantation (rejection) - belatacept [ID87] 00010101
Kidney transplantation (rejection) - everolimus [ID117] 00010101
Knee cartilage defects - autologous chondrocyte implantation [ID686] 00010101
KRAS mutation testing of tumours in adults with metastatic colorectal cancer (discontinued) 00010101
Leukaemia (acute lymphoblastic) - dasatinib [ID386] 00010101
Leukaemia (chronic lymphocytic) - ibrutinib [ID749] 20160601
Leukaemia (chronic lymphocytic) - obinutuzumab (with chlorambucil, 1st line) [ID650] 20150501
Leukaemia (chronic lymphocytic, previously treated) - idelalisib [ID764] 20151001
Leukaemia (chronic lymphocytic, previously untreated) - ofatumumab [ID642] 20150501
Leukaemia (chronic lymphocytic, relapsed) - ofatumumab (maintenance) [ID732] 20160901
Leukaemia (chronic myeloid) - nilotinib (discontinued) [ID79] 20110501
Levitronix CentriMag for treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency in adult and paediatric patients 00010101
Lipid modification 20150901
Liver disease (non-alcoholic fatty [NAFLD]) 20160701
Living-donor liver transplantation 00010101
Low back pain and sciatica 20161101
Low-energy contact X-ray brachytherapy (the Papillon technique) for early-stage rectal cancer 00010101
Lower urinary tract symptoms (update SC) 20150601
Lung cancer (non-small cell) - afatinib [ID357] 00010101
Lung cancer (non-small cell) - erlotinib and gefitinib (post chemotherapy) (rev TA162, TA175) [ID620] 00010101
Lung cancer (non-small cell) - nintedanib [ID438] 20150501
Lung cancer (non-small cell, advanced, inoperable) - liposomal cisplatin (with chemotherapy) [ID657] 00010101
Lung cancer (non-small-cell) - cetuximab [ID9] 00010101
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (in combination with bevacizumab) [ID44] 00010101
Lung cancer (non-small-cell, advanced or metastatic second line) - erlotinib (in combination with bevacizumab) [ID43] 00010101
Lung cancer (non-small-cell, advanced, metastatic) - nivolumab (after platinum chemotherapy) [ID811] 20160501
Lung cancer (non-small-cell, anaplastic lymphoma kinase positive, previously treated) - ceritinib [ID729] 20160101
Lung cancer (non-small-cell, second line treatment) - vandetanib [ID46] 00010101
Lung transplantation with ex-vivo perfusion 20130921
Lymphoma (follicular non Hodgkin's - advanced) - bortezomib [ID407] 00010101
Lymphoma (Hodgkin's, CD30-positive) - brentuximab vedotin (after autologous stem cell transplant) [ID722] 20160701
Lymphoma (mantle cell) - bendamustine (1st line, with rituximab) [ID609] 00010101
Lymphoma (mantle cell, relapsed, refractory) - ibrutinib [ID753] 20161201
Lymphoma (mantle cell, relapsed, refractory) - lenalidomide [ID739] 20160701
Lymphoma (mantle cell, untreated) - bortezomib [ID724] 20160201
Lymphoma (non Hodgkin's) - bendamustine (with rituximab) [ID434] 00010101
Lymphoma (non Hodgkin's, peripheral T-cell) - pralatrexate [ID368] 00010101
Macular degeneration 20170801
Macular oedema (diabetic) - aflibercept [ID717] 20150601
Macular oedema (diabetic) - dexamethasone intravitreal implant [ID653] 20150601
Macular oedema (diabetic) - pegaptanib sodium [ID452] 00010101
Major depressive disorder - vortioxetine [ID583] 20150901
Major trauma 20160201
Major trauma services 20160201
Management and organisational approaches to safe staffing 20160201
Managing medicines for people receiving social care in the community 20170401
Maternal and child nutrition - improving nutritional status 20150701
Medicines optimisation 20160301
Medtech Innovation Briefings (MIBs) 00010101
Melanoma 20150701
Melanoma (advanced and metastatic) - temozolomide [ID316] 00010101
Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib [ID661] 20160601
Melanoma (metastatic) - paclitaxel albumin-bound nanoparticles (1st line) [ID570] 00010101
Melanoma (metastatic) - talimogene laherparepvec [ID508] 20160701
Melanoma (resected stage IV, high risk stage III) - ipilimumab (adjuvant) [ID721] 00010101
Melanoma (unresectable, metastatic) - pembrolizumab (after ipilimumab) [ID760] 20151201
Melanoma (unresectable, metastatic, ipilimumab naive) - pembrolizumab [ID801] 20160101
Menopause 20151001
Mental health community settings 00010101
Mental health of adults in contact with the criminal justice system 20161101
Mental health problems in people with learning disabilities 20160901
Motor Neurone Disease 20160201
MRI guided focussed ultrasound for chronic pain 00010101
Mucopolysaccharidosis (type IVA) - elosulfase alfa [ID744] 20151001
Multimorbidities: system integration to meet population needs (topic deferred until further notice) 00010101
Multimorbidity: clinical assessment and management 20160901
Multiple myeloma - bortezomib (consolidation therapy) [ID529] 00010101
Multiple myeloma - lenalidomide (maintenance, post autologous stem cell transplantation) [ID475] 00010101
Multiple myeloma - lenalidomide (post bortezomib) (part rev TA171) [ID667] 00010101
Multiple myeloma - panobinostat (post 1 prior therapy) [ID663] 20160101
Multiple myeloma (newly diagnosed) - lenalidomide [ID474] 20160401
Multiple myeloma (one prior therapy) - vorinostat (with bortezomib) [ID501] 00010101
Multiple myeloma (relapsed, refractory) - carfilzomib (after prior therapy) [ID677] 00010101
Multiple myeloma and related disorders - Freelite assays (and alternative technologies identified during scoping) for diagnosis in primary care 00010101
Multiple sclerosis 20160101
Multiple sclerosis - cladribine [ID64] 00010101
Multiple sclerosis - sativex [ID387] 00010101
Multiple sclerosis (primary-progressive) - fingolimod [ID62] 00010101
Multiple sclerosis (relapsing-remitting) - laquinimod [ID560] 00010101
Myelofibrosis (splenomegaly, symptoms) - ruxolitinib (review TA289) [ID831] 20160201
Myeloma 20160201
Neonatal Jaundice (update SC) 20151101
Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799] 20160401
Non-Hodgkin's lymphoma 20160701
Obesity - adults and children 20160501
Obesity - lorcaserin [ID337] 00010101
Obesity - phentermine (with topiramate) [ID543] 00010101
Obesity - prevention and lifestyle weight management in children 20150701
Obesity, overweight with risk factors - naltrexone-bupropion (prolonged release) [ID757] 00010101
Obesity: prevention and management in adults 00010101
Older people - independence and mental wellbeing 20151101
Oral health for adults in care homes 20160601
Oral health promotion approaches for dental teams 20151001
OraQuick® HCV Rapid Antibody Test - not proceeding 00010101
Organ rejection (liver transplantation, prevention) - everolimus [ID559] 20150601
Osteoarthritis 20150601
Osteoarthritis - diacerein [ID332] 00010101
Osteoarthritis - naproxcinod [ID417] 00010101
Osteoarthritis and rheumatoid arthritis - cox-II inhibitors (review) [ID388] 00010101
Osteoporosis (prevention) - bisphosphonates (inc part rev TA160, TA161) [ID782] 20151101
Ovarian (epithelial), fallopian and peritoneal cancer - pazopanib (maintenance) [ID545] 00010101
Ovarian (epithelial), fallopian tube, peritoneal cancer (relapsed, platinum-resistant) - bevacizumab [ID684] 00010101
Ovarian cancer - topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent disease only (Review of TA 91 and TA 222) [ID468] 00010101
Ovarian cancer - vintafolide (with pegylated liposomal doxorubicin) [ID564] 00010101
Ovarian, fallopian tube and peritoneal cancer (BRCA 1 or 2, mutated, relapsed, platinum-sensitive) - olaparib (maintenance) [ID735] 20150901
Pancreatic adenocarcinoma (untreated, metastatic) - paclitaxel albumin-bound nanoparticles (with gemcitabine) [ID680] 00010101
Pancreatic cancer - capectitabine [ID389] 00010101
Pancreatic cancer (locally advanced, metastatic) - masitinib [ID566] 00010101
Pancreatic cancer (metastatic) - nimotuzumab (1st line) [ID513] 00010101
Pancreatic cancer (metastatic, untreated) - liposomal cisplatin (with gemcitabine) [ID658] 00010101
Parkinson's disease (update) 20170401
Percutaneous coblation of the intervertebral disc for lower back pain and sciatica 00010101
Percutaneous electrothermal heat therapy of the Intervertebral disc annulus for lower back pain and sciatica 00010101
Percutaneous endoscopic laser lumbar discectomy 00010101
Percutaneous interlaminar endoscopic lumbar discectomy 00010101
Percutaneous intradiscal radiofrequency thermocoagulation of the disc nucleus for lower back pain and sciatica 00010101
Percutaneous transforaminal endoscopic lumbar discectomy 00010101
Peroral endoscopic myotomy (POEM) for achalasia 00010101
Personality disorders (borderline and antisocial) 20150601
Physical health of people in prison 20161101
Pneumonia 20160101
Polycythaemia vera - ruxolitinib (after hydroxycarbamide) [ID734] 20160101
Preoperative high dose rate brachytherapy for rectal cancers 00010101
Preoperative tests (update) 20160401
Pressure ulcers 20150601
Preterm labour and birth 20151101
Preventing unintentional injury 00010101
Prophylaxis against infective endocarditis (Standing Committee A update) 20150901
Prostate cancer 20150601
Prostate cancer - intensity modulated radiotherapy [ID17] 00010101
Prostate cancer (advanced, hormone dependent) - degarelix depot [ID590] 20150601
Prostate cancer (hormone refractory) - atrasentan [ID390] 00010101
Prostate cancer (hormone relapsed, bone metastases) - radium-223 dichloride [ID576] 20150701
Prostate cancer (metastatic, hormone relapsed, not treated with chemotherapy) - abiraterone acetate (with prednisolone) [ID503] 00010101
Prostate cancer (metastatic, hormone-relapsed) - enzalutamide [ID683] 20150901
Prostate cancer (prevention) - dutasteride [ID75] 00010101
Psoriasis - briakinumab (suspended) [ID65] 00010101
Psoriasis (plaque, moderate to severe) - apremilast [ID679] 20150801
Psoriatic arthritis (active) - apremilast (after-DMARDs) 20150801
Psoriatic arthritis (active) - ustekinumab (Rapid Rev TA313) [ID819] 20150501
Psoriatic arthritis (moderate to severe) - leflunomide [ID391] 00010101
Pulmonary arterial hypertension (adults) - drugs [ID12] 00010101
Radiofrequency ablation for gastric antral vascular ectasia 00010101
Radiofrequency ablation for symptomatic interdigital (mortons) nerurom 00010101
Renal cell carcinoma (second line metastatic) - pazopanib [ID70] 20110101
Rheumatoid arthritis - adalimumab, etanercept and infliximab (sequential use) [ID18] 00010101
Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review [ID537] 20151001
Rheumatoid arthritis - tofacitinib [ID526] 00010101
Rheumatoid arthritis (after the failure of conventional DMARDs) -rituximab [ID333] 00010101
Rheumatoid arthritis (standing committee A update) 20151201
Sacral nerve stimulation for chronic non-obstructive urinary retention 00010101
Safety and 6 month effectiveness of minimally invasive SI joint fusion for back pain 00010101
School based interventions to prevent smoking (partial update) 00010101
Secondary prevention of myocardial infarction 20150901
Secukinumab for treating moderate to severe plaque psoriasis [ID718] 20150701
Sepsis 20160701
Sepsis: The LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi 20160301
Service model for people with learning disabilities and challenging behaviour 20170901
Service user and carer experience 20180101
Severe mental illness and substance misuse (dual diagnosis) - community health and social care services 20160901
Sexual health - condom distribution schemes 20170101
Short-term interventions for regaining independence 20170701
SILK artery reconstruction device 00010101
Skin cancer: the VivaScope 1500 and 3000 systems for detecting and monitoring skin lesions 20151101
Smoking - harm reduction 20150701
Smoking cessation (update) 00010101
Social and emotional wellbeing in primary and secondary education (update) 00010101
Social care of older people with multiple long-term conditions 20151001
Soft tissue or bone sarcoma (metastatic) - ridaforolimus (maintenance) [ID415] 00010101
Spasticity (after stroke) - botulinum toxin type A [ID768] 20160701
Spectra Optia apheresis device for automatic red blood cell exchange in patients with sickle cell disease 20160201
Spinal injury assessment 20160201
Spineform Hemibridge endoscopic vertebral stapling to reduce curvature in the growing scoliotic spine in children 00010101
Spondyloarthritis 20161201
Stroke (quality standards update) 20160401
Sunlight exposure - benefits and risks 20150701
Suspected cancer (update) 20150601
Suture fixation of the distal tibiofibular syndesmosis 00010101
Systemic lupus erythematosus - prasterone [ID392] 00010101
Systemic lupus erythematosus (autoantibody-positive) - belimumab [ID416] 20150401
T-cell lymphoma (peripheral, relapsed or refractory) - romidepsin [ID504] 00010101
The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites 20150701
The safe use and management of controlled drugs 20160301
The Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test and BRAHMS sFlt-1 Kryptor / PlGF plus Kryptor PE ratio to aid the assessment of suspected pre-eclampsia 20160301
Thrombophilia [ID393] 00010101
Transcatheter valve-in-valve implantation for the treatment of mitral valve 00010101
Transcranial magnetic stimulation for severe depression 00010101
Transfusion 20151101
Transition between inpatient hospital settings and community or care home settings for adults with social care needs 20151101
Transition between inpatient mental health settings and community and care home settings 20160801
Transition from children's to adult services 20160201
Tuberculosis (update) 20151001
Tuberculosis (update) 20151001
Type 1 Diabetes (update) 20150801
Type 1 diabetes: Integrated sensor-augmented pump therapy systems for managing blood glucose levels (The MiniMed Paradigm Veo System and the Vibe and G4 PLATINUM CGM system) 20160101
Type 2 diabetes 20150801
Ulcerative colitis (moderate to severely active) - vedolizumab [ID691] 20150601
Ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis 00010101
Ultrasound enhanced catheter-directed thrombolysis for pulmonary embolism 00010101
Upper aerodigestive tract cancer 20160201
Urinary tract infection in adults 20150601
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia 20150901
Urticaria (chronic spontaneous, previously treated) - omalizumab [ID707] 20150501
Venous leg ulcers - new treatments [ID394] 00010101
Venous thromboembolic diseases - management (Standing Committee B update) 20151101
Venous thromboembolism - apixaban (acute medical illness) [ID310] 00010101
Venous Thromboembolism - reducing the risk 20150601
Venous thromboembolism (prevention) - rivaroxaban [ID463] 00010101
Venous thromboembolism (recurrent) - idraparinux sodium [ID395] 00010101
Venous thromboembolism (VTE) - ximelagatran [ID396] 00010101
Violence and aggression (update) 20150501
Virtual Touch Quantification to diagnose and monitor liver fibrosis 00010101
Winter deaths - preventing excess winter deaths 00010101
Workplace health - older employees 20160201
Workplace health: support for employees with disabilities and long term conditions 20170201
Workplace policy and management practices to improve the health and wellbeing of employees 20150601
Xpert MTB/RIF assay (and alternative technologies identified during scoping) 00010101
Get involved